138 related articles for article (PubMed ID: 24732031)
1. Bone abnormal signal incidentally found in pre-biopsy diffusion-weighted MRI for suspected prostate cancer: what does it reflect?
Yachida Y; Yoshida S; Takeshita H; Sawamura C; Tanaka H; Satoh S; Uchida Y; Ishioka J; Matsuoka Y; Numao N; Koga F; Saito K; Fujii Y; Kihara K
Urol Int; 2014; 93(2):170-5. PubMed ID: 24732031
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic significance of high signal intensity on diffusion-weighted MR imaging in the ureter, urethra, prostate and bone of patients with bladder cancer.
Takeuchi M; Suzuki T; Sasaki S; Ito M; Hamamoto S; Kawai N; Kohri K; Hara M; Shibamoto Y
Acad Radiol; 2012 Jul; 19(7):827-33. PubMed ID: 22341371
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the prostate imaging reporting and data system for the detection of prostate cancer by the results of targeted biopsy of the prostate.
Baur AD; Maxeiner A; Franiel T; Kilic E; Huppertz A; Schwenke C; Hamm B; Durmus T
Invest Radiol; 2014 Jun; 49(6):411-20. PubMed ID: 24598440
[TBL] [Abstract][Full Text] [Related]
5. Diffusion-weighted magnetic resonance imaging in prostate cancer patients on active surveillance one year after diagnosis and before repeat biopsy.
Vasarainen H; Lahdensuo K; Savolainen R; Ruutu M; Taari K; Rannikko A
Scand J Urol; 2013 Dec; 47(6):456-61. PubMed ID: 23327661
[TBL] [Abstract][Full Text] [Related]
6. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI.
Kim CK; Park BK; Lee HM
J Magn Reson Imaging; 2009 Feb; 29(2):391-7. PubMed ID: 19161194
[TBL] [Abstract][Full Text] [Related]
7. [The clinical value of 3 tesla diffusion-weighted magnetic resonance imaging in the diagnosis of prostate cancer].
Shimamoto T; Ashida S; Yamasaki I; Kuno T; Fukuhara H; Fukata S; Satake H; Tamura K; Karashima T; Kamata M; Inoue K; Shuin T; Kariya S; Ogawa Y
Hinyokika Kiyo; 2012 Mar; 58(3):143-8. PubMed ID: 22495042
[TBL] [Abstract][Full Text] [Related]
8. 3D high-resolution diffusion-weighted MRI at 3T: Preliminary application in prostate cancer patients undergoing active surveillance protocol for low-risk prostate cancer.
Nguyen C; Sharif-Afshar AR; Fan Z; Xie Y; Wilson S; Bi X; Payor L; Saouaf R; Kim H; Li D
Magn Reson Med; 2016 Feb; 75(2):616-26. PubMed ID: 25761871
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer detection: comparison of T2-weighted imaging, diffusion-weighted imaging, proton magnetic resonance spectroscopic imaging, and the three techniques combined.
Chen M; Dang HD; Wang JY; Zhou C; Li SY; Wang WC; Zhao WF; Yang ZH; Zhong CY; Li GZ
Acta Radiol; 2008 Jun; 49(5):602-10. PubMed ID: 18568549
[TBL] [Abstract][Full Text] [Related]
10. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
[TBL] [Abstract][Full Text] [Related]
11. Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations.
Reischauer C; Froehlich JM; Koh DM; Graf N; Padevit C; John H; Binkert CA; Boesiger P; Gutzeit A
Radiology; 2010 Nov; 257(2):523-31. PubMed ID: 20829534
[TBL] [Abstract][Full Text] [Related]
12. Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical analysis of the literature.
Giannarini G; Petralia G; Thoeny HC
Eur Urol; 2012 Feb; 61(2):326-40. PubMed ID: 22000497
[TBL] [Abstract][Full Text] [Related]
13. Apparent diffusion coefficient value and ratio as noninvasive potential biomarkers to predict prostate cancer grading: comparison with prostate biopsy and radical prostatectomy specimen.
De Cobelli F; Ravelli S; Esposito A; Giganti F; Gallina A; Montorsi F; Del Maschio A
AJR Am J Roentgenol; 2015 Mar; 204(3):550-7. PubMed ID: 25714284
[TBL] [Abstract][Full Text] [Related]
14. Tumor lesion diameter on diffusion weighted magnetic resonance imaging could help predict insignificant prostate cancer in patients eligible for active surveillance: preliminary analysis.
Lee DH; Koo KC; Lee SH; Rha KH; Choi YD; Hong SJ; Chung BH
J Urol; 2013 Oct; 190(4):1213-7. PubMed ID: 23727188
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of bone metastases from prostate cancer and benign red marrow depositions of the pelvic bone with multiparametric MRI.
Park S; Park JG; Jun S; Kim H; Kim TS; Kang H
Magn Reson Imaging; 2020 Nov; 73():118-124. PubMed ID: 32860869
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of prebiopsy multifunctional and morphologic MRI combined with free-to-total prostate-specific antigen ratio in the detection of prostate cancer.
Vilanova JC; Barceló-Vidal C; Comet J; Boada M; Barceló J; Ferrer J; Albanell J
AJR Am J Roentgenol; 2011 Jun; 196(6):W715-22. PubMed ID: 21606259
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer: relationships between postbiopsy hemorrhage and tumor detectability at MR diagnosis.
Tamada T; Sone T; Jo Y; Yamamoto A; Yamashita T; Egashira N; Imai S; Fukunaga M
Radiology; 2008 Aug; 248(2):531-9. PubMed ID: 18539890
[TBL] [Abstract][Full Text] [Related]
18. [Utility of diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient in detection of prostate cancer and prediction of pathologic Gleason score].
Kagebayashi Y; Nakai Y; Matsumoto Y; Samma S; Miyasaka T; Nakagawa H
Hinyokika Kiyo; 2012 Aug; 58(8):405-8. PubMed ID: 23052263
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer detection with 3-T MRI: comparison of diffusion-weighted and T2-weighted imaging.
Miao H; Fukatsu H; Ishigaki T
Eur J Radiol; 2007 Feb; 61(2):297-302. PubMed ID: 17085002
[TBL] [Abstract][Full Text] [Related]
20. Value of diffusion-weighted imaging for the prediction of prostate cancer location at 3T using a phased-array coil: preliminary results.
Kim CK; Park BK; Lee HM; Kwon GY
Invest Radiol; 2007 Dec; 42(12):842-7. PubMed ID: 18007156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
